COGENT

• Research type

  Research Study

• Full title

  A Randomized, Double-Blind, Sham and Active-Controlled, Parallel-Group Phase 2/3 study to evaluate the Efficacy and Safety of SX600 administered via transforaminal epidural injection in Patients with Unilateral Radicular Pain Secondary to Lumbar Intervertebral Disc

• IRAS ID

  1007634

• Contact name

  Jeffrey Missling

• Contact email

  jmissling@spinethera.com

• Sponsor organisation

  SpineThera, Inc.

• Research summary

  Trial investigating SX600 against placebo in patients suffering from pain caused by disc herniation.

• REC name

  East of Scotland Research Ethics Service REC 2

• REC reference

  23/ES/0021

• Date of REC Opinion

  20 Dec 2023

• REC opinion

  Further Information Unfavourable Opinion